As a research-driven company, we are part of the collective effort in fighting COVID-19. Boehringer Ingelheim does not develop human vaccines, however, drawing from our different areas of expertise, we engage in a number of activities to find medical solutions to this pandemic, working closely with academic researchers, international institutions and others in the pharma industry.

NP-IE-100570 | December 2021 

Overview of initiatives:

More related content